Does rapid genetic counseling and testing in newly diagnosed breast cancer patients cause additional psychosocial distress? results from a randomized clinical trial
Marijke R. Wevers(Radboud University Nijmegen), Neil K. Aaronson(The Netherlands Cancer Institute), Arjen J. Witkamp(University Medical Center Utrecht), Jacobien M. Kieffer(Norwegian Womens Public Health Association), Margreet G.E.M. Ausems(McGill University Health Centre), Marnix A. de Roos(Ziekenhuis Rivierenland), Eline Vriens(Tergooi), Daniela Hahn(The Netherlands Cancer Institute), Thijs van Dalen(Erasmus MC), B van Ooijen(Rotterdam University of Applied Sciences), Wim H. Bouma(Gelre Hospitals), Titia Brouwer(Utrecht University), Eveline M. A. Bleiker(Cancer Clinic), Rob B. van der Luijt(Institute for Quality and Efficiency in Health Care), Heiðdís Valdimarsdóttir(Reykjavík University), Frans B.L. Hogervorst(The Netherlands Cancer Institute), Johannes P. Vente, Paul J. Borgstein(OLVG), Senno Verhoef(The Netherlands Cancer Institute), Bart C. Vrouenraets(The Netherlands Cancer Institute), Herman Rijna(Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital), E. Theunissen(St. Antonius Ziekenhuis), Emiel J. Rutgers(Oncode Institute)
Cited by 33
Related Papers
Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries
|Journal of Clinical Epidemiology|1998|2.9k
EORTC QLQ-C30 Scoring Manual
|Research at the University of Copenhagen (University of Copenhagen)|1995|2.4k
Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations
|Journal of Clinical Epidemiology|1998|2.3k
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
|New England Journal of Medicine|2016|2k